Matthew Scott Sigman

Title: Matthew Scott Sigman: Innovator in Therapeutic Compounds

Introduction

Matthew Scott Sigman is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of chemistry, particularly in the development of therapeutic compounds. With a total of 3 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

One of his latest patents is titled "Compositions and methods comprising 2-(acylamino)imidazoles." This invention presents 2-(acylamino)imidazoles with therapeutic activity, including selective activity against cancer cells. The patent also details methods of using and preparing these compounds. Another notable patent is for "Quinoline-oxazoline compounds and their use in oxidation synthesis." This patent describes a quinoline-oxazoline compound that can be complexed with a suitable coordination center, such as catalytically active palladium, making it highly useful in catalytically oxidizing alkenes with high regioselectivity.

Career Highlights

Matthew has worked with the University of Utah Research Foundation and Curza Global, LLC, where he has applied his expertise in chemistry to advance research and development. His innovative work has positioned him as a key figure in his field.

Collaborations

Throughout his career, Matthew has collaborated with notable individuals such as Ryan E Looper and Rachel M Vaden. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

Matthew Scott Sigman is a dedicated inventor whose work in therapeutic compounds has the potential to make a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing science and technology.